These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21188465)

  • 1. Everolimus-related organizing pneumonia: a report establishing causality.
    Frija J; Joly D; Knebelmann B; Dusser D; Burgel PR
    Invest New Drugs; 2012 Jun; 30(3):1244-7. PubMed ID: 21188465
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.
    Sánchez-Fructuoso AI; Ruiz JC; Pérez-Flores I; Gómez Alamillo C; Calvo Romero N; Arias M
    Transplant Proc; 2010 Oct; 42(8):3050-2. PubMed ID: 20970607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Everolimus and azoospermia, a causal relationship? About one case in a renal transplant patient].
    Wetzstein M; Weestel PF; Choukroun G
    Nephrol Ther; 2014 Feb; 10(1):44-5. PubMed ID: 24374233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Everolimus-associated pneumonitis in adult liver transplant recipient].
    Marín-Gómez LM; Cordero-Matía E; Gómez-Bravo MÁ; Bernal-Bellido C
    Med Clin (Barc); 2010 Sep; 135(9):431-2. PubMed ID: 19819477
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors.
    Carbonnaux M; Molin Y; Souquet PJ; Tantin A; Lombard-Bohas C; Walter T
    Invest New Drugs; 2014 Dec; 32(6):1308-10. PubMed ID: 25119297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus: a new mammalian target of rapamycin inhibitor for the treatment of advanced renal cell carcinoma.
    Grgic T; Mis L; Hammond JM
    Ann Pharmacother; 2011 Jan; 45(1):78-83. PubMed ID: 21177421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonitis associated with mammalian target of rapamycin inhibitors in renal transplant recipients: a single-center experience.
    Errasti P; Izquierdo D; Martín P; Errasti M; Slon F; Romero A; Lavilla FJ
    Transplant Proc; 2010 Oct; 42(8):3053-4. PubMed ID: 20970608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria associated with mTOR inhibitors after kidney transplant.
    Guney M; Sahin G; Yilmaz B; Canbakan M; Gucun M; Kayatas K; Eren P; Titiz I
    Exp Clin Transplant; 2014 Dec; 12(6):539-42. PubMed ID: 25489805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early everolimus-induced pneumonitis in a renal transplant recipient: A case report.
    Sułkowska K; Palczewski P; Miszewska-Szyszkowska D; Durlik M; Gołębiowski M; Małkowski P
    Ann Transplant; 2012 Dec; 17(4):144-8. PubMed ID: 23274336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung injury associated with mTOR inhibitors (sirolimus and everolimus).
    Conti V; Grazia M; Romagnoli M; Poletti G; Cristino S; Ciliberti G; Piciucchi S; Mosconi G; Poletti V
    Minerva Urol Nefrol; 2014 Dec; 66(4):283-5. PubMed ID: 25531195
    [No Abstract]   [Full Text] [Related]  

  • 11. Everolimus: a guide to its use in liver transplantation.
    Keating GM; Lyseng-Williamson KA
    BioDrugs; 2013 Aug; 27(4):407-11. PubMed ID: 23696253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus-associated pneumonitis in 3 heart transplant recipients.
    Otton J; Hayward CS; Keogh AM; Glanville AR; Macdonald PS
    J Heart Lung Transplant; 2009 Jan; 28(1):104-6. PubMed ID: 19134540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can patients maintain their use of everolimus until lung transplantation?
    Costa AN; Baldi BG; de Oliveira Braga Teixeira RH; Samano MN; de Carvalho CR
    Transplantation; 2015 Jun; 99(6):e42-3. PubMed ID: 26035277
    [No Abstract]   [Full Text] [Related]  

  • 14. Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options.
    Schrader J; Sterneck M; Klose H; Lohse AW; Nashan B; Fischer L
    Transpl Int; 2010 Jan; 23(1):110-3. PubMed ID: 19497063
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe everolimus-associated pneumonitis in a renal transplant recipient.
    Alexandru S; Ortiz A; Baldovi S; Milicua JM; Ruíz-Escribano E; Egido J; Plaza JJ
    Nephrol Dial Transplant; 2008 Oct; 23(10):3353-5. PubMed ID: 18658177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial pneumonitis as an adverse reaction to mTOR inhibitors.
    Molas-Ferrer G; Soy-Muner D; Anglada-Martínez H; Riu-Viladoms G; Estefanell-Tejero A; Ribas-Sala J
    Nefrologia; 2013; 33(3):297-300. PubMed ID: 23712219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinoma.
    Loron MC; Grange S; Guerrot D; Di Fiore F; Freguin C; Hanoy M; Le Roy F; Poussard G; Etienne I; Legallicier B; Pfister C; Godin M; Bertrand D
    J Clin Oncol; 2015 Mar; 33(8):e45-7. PubMed ID: 24638002
    [No Abstract]   [Full Text] [Related]  

  • 18. Focus.
    Shouval D
    J Hepatol; 2011 Aug; 55(2):243-4. PubMed ID: 21554907
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninfectious pneumonitis in a patient with renal cell carcinoma treated with everolimus.
    Creel P; Moldawer NP
    Oncol Nurs Forum; 2011 Mar; 38(2):125-8. PubMed ID: 21356651
    [No Abstract]   [Full Text] [Related]  

  • 20. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient--not all proliferation signal inhibitors are the same: a case report.
    De Simone P; Petruccelli S; Precisi A; Carrai P; Doria R; Menichetti F; Filipponi F
    Transplant Proc; 2007 Dec; 39(10):3500-1. PubMed ID: 18089420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.